Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients

AIDS

Volumn 13, Issue 2, 1999, Pages 225-229

  Gallant, Joel E ^a   Chaisson, Richard E ^a   Keruly, Jeanne C ^a   Moore, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral sequencing; Stavudine; Zidovudine; Zidovudine experienced; Ziovudine naive

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; AGE; ARTICLE; DATA ANALYSIS; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; ZIDOVUDINE;

EID: 0033006130     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199902040-00010     Document Type: Article

References (9)

1. Katlama C, Valantin M, Matheron S, et al.: Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection. Ann Intern Med 1998; 129:525-531.
2. Sommadossi JP, Zhou XJ, Moore J, et al.: Impairment of stavudine (d4T) phosphorylation in patients receiving a combination of zidovudine (ZDV) and d4T (ACTG 290). Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, February 1998 [abstract 3].
3. Murray HW, Squires KE, Weiss W, et al.: Stavudine in patients with AIDS and AIDS-related complex: ACTG 089. J Infect Dis 1995, 171 (suppl 2):S123-S130.
4. Fischl MA, Richmann DD, Grieco MH, et al.: The efficacy of AZT in the treatment of patients with AIDS and ARC. N Engl J Med 1987, 317:185-191.
5. Feinberg MB, Carpenter C, Fauci AS, et al.: Report of the NIH Panel Define Principles of Therapy of HIV Infection and guidelines for the use of antiretroviral agents in HIV infected adults and adolescents. Ann Intern Med 1998, 128:1057-1100.
6. Carpenter CCI, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 1998, 280:78-86.
7. Liang K-Y, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
8. Moore RD, Keruly JC, Gallant JE, Chaisson RF: Response to therapy with protease inhibitors in clinical practice. 12th World AIDS Conference. Geneva, June-July 1998 [abstract 22347].
9. Deeks S, Beally G, Cohen PT, Grant R, Volberding P: Viral load and CD4+ T cell changes in patients failing potent protease inhibitor therapy. Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, February 1998 [abstract 419].